Assembly Biosciences Announces September Conference Participation
August 31, 2017 07:00 ET
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Assembly Biosciences to Present Data on ABI-H0731 at AASLD 2016 Liver Meeting
November 11, 2016 08:00 ET
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Nov. 11, 2016 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...